Skip to main content
News and Products

Early termination of trial of endovascular therapy

By 17th October 2017February 1st, 2019No Comments

The DEFUSE 3 (Endovascular Therapy Following Imaging Evaluation for Ischemic Stroke 3) trial is a prospective randomized phase III multicenter

controlled trial of patients with acute ischemic anterior circulation strokes due to large artery occlusion treated between six and 16 hours of stroke onset with endovascular thrombectomy therapy plus standard medical therapy versus standard medical therapy.

Read More